109 related articles for article (PubMed ID: 33531426)
1. A Presynaptic Protein Is a Net Gain for Pancreatic Tumor Progression.
Sherman MH
Cancer Discov; 2021 Feb; 11(2):230-232. PubMed ID: 33531426
[TBL] [Abstract][Full Text] [Related]
2. A Single-Cell Window into Pancreas Cancer Fibroblast Heterogeneity.
Belle JI; DeNardo DG
Cancer Discov; 2019 Aug; 9(8):1001-1002. PubMed ID: 31371323
[TBL] [Abstract][Full Text] [Related]
3. Two Birds with One Stone: Therapeutic Targeting of IL1α Signaling Pathways in Pancreatic Ductal Adenocarcinoma and the Cancer-Associated Fibroblasts.
Ling J; Chiao PJ
Cancer Discov; 2019 Feb; 9(2):173-175. PubMed ID: 30737215
[TBL] [Abstract][Full Text] [Related]
4. Unlocking the Role of Age-Related Changes to Fibroblasts in Pancreatic Cancer.
Isaacson A; Barki D; Scherz-Shouval R
Cancer Res; 2024 Apr; 84(8):1185-1187. PubMed ID: 38616657
[TBL] [Abstract][Full Text] [Related]
5. The Few yet Fab
Cukierman E
Cancer Discov; 2022 Feb; 12(2):296-298. PubMed ID: 35140177
[TBL] [Abstract][Full Text] [Related]
6. Fibroblasts in Pancreatic Ductal Adenocarcinoma: Biological Mechanisms and Therapeutic Targets.
Whittle MC; Hingorani SR
Gastroenterology; 2019 May; 156(7):2085-2096. PubMed ID: 30721663
[TBL] [Abstract][Full Text] [Related]
7. Synergistic cytotoxicity and co-autophagy inhibition in pancreatic tumor cells and cancer-associated fibroblasts by dual functional peptide-modified liposomes.
Chen X; Yu Q; Liu Y; Sheng Q; Shi K; Wang Y; Li M; Zhang Z; He Q
Acta Biomater; 2019 Nov; 99():339-349. PubMed ID: 31499197
[TBL] [Abstract][Full Text] [Related]
8. The prognostic significance of cancer-associated fibroblasts in pancreatic ductal adenocarcinoma.
Park H; Lee Y; Lee H; Kim JW; Hwang JH; Kim J; Yoon YS; Han HS; Kim H
Tumour Biol; 2017 Oct; 39(10):1010428317718403. PubMed ID: 29025374
[TBL] [Abstract][Full Text] [Related]
9. Deconstructing Pancreatic Adenocarcinoma by Targeting the Conductor, MYC.
English IA; Sears RC
Cancer Discov; 2020 Apr; 10(4):495-497. PubMed ID: 32238397
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic Fibroblast Heterogeneity: From Development to Cancer.
Garcia PE; Scales MK; Allen BL; Pasca di Magliano M
Cells; 2020 Nov; 9(11):. PubMed ID: 33198201
[TBL] [Abstract][Full Text] [Related]
11. The Golgi: Keeping It Unapologetically Basic.
Ward NP; DeNicola GM
Cancer Discov; 2020 Jun; 10(6):768-770. PubMed ID: 32482665
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibitors provoke a tumor supportive phenotype in pancreatic cancer associated fibroblasts.
Nguyen AH; Elliott IA; Wu N; Matsumura C; Vogelauer M; Attar N; Dann A; Ghukasyan R; Toste PA; Patel SG; Williams JL; Li L; Dawson DW; Radu C; Kurdistani SK; Donahue TR
Oncotarget; 2017 Mar; 8(12):19074-19088. PubMed ID: 27894105
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in understanding cancer-associated fibroblasts in pancreatic cancer.
Huang H; Brekken RA
Am J Physiol Cell Physiol; 2020 Aug; 319(2):C233-C243. PubMed ID: 32432930
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil extracellular traps promote liver micrometastasis in pancreatic ductal adenocarcinoma via the activation of cancer‑associated fibroblasts.
Takesue S; Ohuchida K; Shinkawa T; Otsubo Y; Matsumoto S; Sagara A; Yonenaga A; Ando Y; Kibe S; Nakayama H; Iwamoto C; Shindo K; Moriyama T; Nakata K; Miyasaka Y; Ohtsuka T; Toma H; Tominaga Y; Mizumoto K; Hashizume M; Nakamura M
Int J Oncol; 2020 Feb; 56(2):596-605. PubMed ID: 31894273
[TBL] [Abstract][Full Text] [Related]
15. Loss of BAP1 Leads to More YAPing in Pancreatic Cancer.
Brekken RA
Cancer Res; 2020 Apr; 80(8):1624-1625. PubMed ID: 32295782
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic Tumor Microenvironment.
Wang K; He H
Adv Exp Med Biol; 2020; 1296():243-257. PubMed ID: 34185297
[TBL] [Abstract][Full Text] [Related]
17. IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma.
Biffi G; Oni TE; Spielman B; Hao Y; Elyada E; Park Y; Preall J; Tuveson DA
Cancer Discov; 2019 Feb; 9(2):282-301. PubMed ID: 30366930
[TBL] [Abstract][Full Text] [Related]
18. The Next Wave of Stroma-Targeting Therapy in Pancreatic Cancer.
Huang H; Brekken RA
Cancer Res; 2019 Jan; 79(2):328-330. PubMed ID: 30647067
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast activation protein-α-expressing fibroblasts promote the progression of pancreatic ductal adenocarcinoma.
Kawase T; Yasui Y; Nishina S; Hara Y; Yanatori I; Tomiyama Y; Nakashima Y; Yoshida K; Kishi F; Nakamura M; Hino K
BMC Gastroenterol; 2015 Sep; 15():109. PubMed ID: 26330349
[TBL] [Abstract][Full Text] [Related]
20. Desmoplasia in Lymph Node Metastasis of Pancreatic Adenocarcinoma Reveals Activation of Cancer-Associated Fibroblasts Pattern and T-helper 2 Immune Cell Infiltration.
Nizri E; Bar-David S; Aizic A; Sternbach N; Lahat G; Wolf I; Klausner J
Pancreas; 2019 Mar; 48(3):367-373. PubMed ID: 30768574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
